|
|
|
|
| LEADER |
00000cam a2200000Ii 4500 |
| 001 |
SCIDIR_on1305063150 |
| 003 |
OCoLC |
| 005 |
20231120010637.0 |
| 006 |
m o d |
| 007 |
cr cnu---unuuu |
| 008 |
220323s2022 enk o 000 0 eng d |
| 040 |
|
|
|a OPELS
|b eng
|e rda
|e pn
|c OPELS
|d EBLCP
|d OCLCO
|d N$T
|d OCLCF
|d YDX
|d OCLCQ
|d OCLCO
|d SFB
|
| 019 |
|
|
|a 1304815747
|
| 020 |
|
|
|a 9780323954266
|q (electronic bk.)
|
| 020 |
|
|
|a 032395426X
|q (electronic bk.)
|
| 020 |
|
|
|z 9780323961271
|
| 020 |
|
|
|z 0323961274
|
| 035 |
|
|
|a (OCoLC)1305063150
|z (OCoLC)1304815747
|
| 050 |
|
4 |
|a QR46
|
| 082 |
0 |
4 |
|a 616.9041
|2 23
|
| 100 |
1 |
|
|a Mir, Manzoor Ahmad,
|e author.
|
| 245 |
1 |
0 |
|a Human pathogenic microbes :
|b diseases and concerns /
|c Manzoor Ahmad Mir.
|
| 264 |
|
1 |
|a London, United Kingdom :
|b Academic Press,
|c 2022.
|
| 300 |
|
|
|a 1 online resource (1 volume)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Developments in microbiology
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a Front Cover -- HUMAN PATHOGENIC MICROBES -- HUMAN PATHOGENIC MICROBES: DISEASES AND CONCERNS -- Copyright -- Contents -- List of contributors -- Preface -- Acknowledgments -- Abbreviation list -- Glossary -- 1 -- Human pathogenic microbes (bacterial and fungal) and associated diseases -- 1.1 Introduction -- 1.1.1 Modes of transmission -- 1.2 Human-pathogen interaction -- 1.3 Human pathogenic fungal microorganisms -- 1.3.1 Candida species -- 1.3.2 Aspergillus species -- 1.3.3 Cryptococcus species -- 1.4 Human pathogenic fungal diseases -- 1.4.1 Candidiasis -- 1.4.2 Aspergillosis
|
| 505 |
8 |
|
|a 1.4.3 Cryptococcosis -- 1.5 Human pathogenic bacterial microorganisms -- 1.5.1 Mycobacterium tuberculosis -- 1.5.2 Vibrio cholera -- 1.5.3 Staphylococcus aureus -- 1.6 Human pathogenic bacterial diseases -- 1.6.1 Tuberculosis (TB) -- 1.6.2 Cholera -- 1.6.3 Streptococcus pneumoniae and other associated infections -- 1.7 Summary and future perspectives -- References -- 2 -- Evolution of antimicrobial drug resistance in human pathogenic bacteria -- 2.1 Introduction -- 2.2 Current status of resistance to antibacterial drugs -- 2.3 Surveillance of antibacterial resistance/tolerance
|
| 505 |
8 |
|
|a 2.4 Molecular mechanisms of antimicrobial drug resistance in human pathogenic bacteria -- 2.5 Resistance to antibacterial drugs in selected bacteria of international concern -- 2.5.1 Escherichia coli-resistance to third-generation cephalosporins and fluoroquinolones -- 2.5.2 Klebsiella pneumoniae-resistance to third-generation cephalosporins and to carbapenems -- 2.5.3 Staphylococcus aureus-resistance to methicillin -- 2.5.4 Streptococcus pneumoniae-resistance (nonsusceptibility) to penicillin -- 2.5.5 Nontyphoidal salmonella-resistance to fluoroquinolones
|
| 505 |
8 |
|
|a 2.5.6 Shigella species-resistance to fluoroquinolones -- 2.5.7 Neisseria gonorrhoeae-decreased susceptibility to third-generation cephalosporins -- 2.6 Economic burden of antibacterial resistance and its impacts on human health -- 2.6.1 Health burden -- 2.6.2 Economic burden -- 2.7 Surveillance of antimicrobial drug resistance in disease-specific programs -- 2.7.1 Surveillance of drug-resistant tuberculosis -- 2.7.2 Surveillance of antimalarial therapeutic efficacy and resistance -- 2.7.3 Surveillance of anti-HIV drug resistance -- 2.7.4 Surveillance of anti-influenza drug resistance
|
| 505 |
8 |
|
|a 2.8 Evolution of drug resistance in mycobacterium tuberclosis -- 2.8.1 Global public health response to drug-resistant tuberclosis -- 2.9 Future perspectives -- References -- 3 -- Evolution of antimicrobial drug resistance in human pathogenic fungi -- 3.1 Introduction -- 3.2 Molecular mechanisms governing antimicrobial drug resistance phenomenon in the human pathogenic fungi -- 3.2.1 Transport alteration: drug efflux via overexpression/activation of membrane transporters -- 3.2.2 Target alteration: altered ergosterol biosynthesis -- 3.2.3 Genomic alterations/genomic plasticity
|
| 650 |
|
0 |
|a Medical microbiology.
|
| 650 |
|
0 |
|a Communicable diseases.
|
| 650 |
|
0 |
|a Drug resistance in microorganisms.
|
| 650 |
|
2 |
|a Communicable Diseases
|0 (DNLM)D003141
|
| 650 |
|
6 |
|a Microbiologie m�edicale.
|0 (CaQQLa)201-0004318
|
| 650 |
|
6 |
|a Maladies infectieuses.
|0 (CaQQLa)201-0001354
|
| 650 |
|
7 |
|a Communicable diseases
|2 fast
|0 (OCoLC)fst00869883
|
| 650 |
|
7 |
|a Drug resistance in microorganisms
|2 fast
|0 (OCoLC)fst00898704
|
| 650 |
|
7 |
|a Medical microbiology
|2 fast
|0 (OCoLC)fst01014362
|
| 655 |
|
0 |
|a Electronic books.
|
| 655 |
|
4 |
|a Electronic books.
|
| 776 |
0 |
8 |
|i Print version:
|t HUMAN PATHOGENIC MICROBES.
|d [Place of publication not identified] : ELSEVIER ACADEMIC PRESS, 2022
|z 0323961274
|w (OCoLC)1287925132
|
| 830 |
|
0 |
|a Developments in microbiology.
|
| 856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780323961271
|z Texto completo
|
